Search results for " type 1 diabetes"

showing 8 items of 18 documents

Diabetic ketoacidosis incidence among children withnew-onset type 1 diabetes in Poland and its associationwith COVID-19 outbreak—Two-year cross-secti…

2022

Background: There are several observations that the onset of coronavirus 19 (COVID-19) pandemic was associated with an increase in the incidence of diabetic ketoacidosis (DKA). However, due to heterogeneity in study designs and country-specific healthcare policies, more national-level evidence is needed to provide generalizable conclusions.Objective: To compare the rate of DKA in Polish children diagnosed with type 1 diabetes (T1D) between the first year of COVID-19 pandemic (15 March 2020 to 15 March 2021) and the preceding year (15 March 2019 to 15 March 2020).Methods: Reference centers in 13 regions (covering ~88% of Polish children) retrospectively reported all new-onset T1D cases in ch…

MaleCOVID-19; Poland; children; diabetic ketoacidosis; new-onset diabetes; type 1 diabetes.AdolescentIncidenceEndocrinology Diabetes and MetabolismCOVID-19Diabetic KetoacidosisCross-Sectional StudiesDiabetes Mellitus Type 1Child PreschoolPediatrics Perinatology and Child HealthInternal MedicineHumansFemalePolandChildPandemicsRetrospective StudiesPediatric Diabetes
researchProduct

Association between symptoms of depression, diabetes complications and vascular risk factors in four European cohorts of individuals with type 1 diab…

2020

Aims: To investigate the association between depressive symptomatology and health markers in type 1 diabetes. Methods: Four countries from the InterDiane Consortium had adopted the Finnish Diabetic Nephropathy Study protocol, including the Beck Depression Inventory (BDI). Associations between depression symptomatology, diabetes complications (diabetic nephropathy, proliferative retinopathy, major adverse cardiovascular events [MACE]) and vascular risk factors (metabolic syndrome, body mass index, glycaemic control) were investigated. Results: In a sample of 1046 participants (Croatia n = 99; Finland n = 314; Latvia n = 315; Lithuania n = 318), 13.4% displayed symptoms of depression (BDI sco…

MaleEndocrinology Diabetes and MetabolismDISEASEDiabetic nephropathy0302 clinical medicineEndocrinologyRisk FactorsGLYCEMIC CONTROLSurveys and QuestionnairesPrevalence030212 general & internal medicineDepression (differential diagnoses)2. Zero hungerDepressionGeneral MedicineMiddle AgedMetabolic syndrome3. Good healthEuropeType 1 diabetesFemaleHEALTHAdultmedicine.medical_specialty030209 endocrinology & metabolismRETINOPATHYDiabetes Complications03 medical and health sciencesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansVascular DiseasesType 1 diabetesbusiness.industry616.379-008.64 [udc]Beck Depression InventoryADULTSCAREmedicine.diseaseCross-Sectional StudiesDiabetes Mellitus Type 13121 General medicine internal medicine and other clinical medicineDepression ; Diabetes complications ; Metabolic syndrome ; Type 1 diabetesDiabetes mellitus type 1 ; psychology ; Depression ; Diabetes complications ; Metabolic syndrome ; Cross-sectional studiesSelf ReportMetabolic syndromebusinessBody mass indexMace
researchProduct

Being hospitalized with a newly diagnosed chronic illness - A phenomenological study of children’s lifeworld in the hospital

2012

The impact of a hospital environment on children has rarely been investigated. Recently, however, the perspective of hospitalized children has been taken into account. Being hospitalized and facing an illness represent a dramatic change in a child’s daily life, and the quality of the environment may influence the child’s experiences. The aim of this study was to investigate the experiences of children being hospitalized with newly diagnosed type 1 diabetes and to obtain an increased understanding of the environmental influences on the children’s lifeworld. The study used a hermeneutic phenomenological approach. The design is a combination of observation of the participant, interviews, and p…

MaleGerontologyHealth Knowledge Attitudes Practicemedicine.medical_specialtyLifeworldtype 1 diabetesmedia_common.quotation_subjectNewly diagnosedNursingbodily changeshospital environmentInterviews as TopicVDP::Medical disciplines: 700::Health sciences: 800::Nursing science: 808Empirical StudiesPerceptionAdaptation PsychologicalVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Pediatrics: 760HumansLearningMedicineChildPsychiatrymedia_commonEnvironment method hospitalised children lived experience type 1 diabetesbusiness.industryHealth PolicyLived experiencePerspective (graphical)Peer reviewIssues ethics and legal aspectsAlertnessDiabetes Mellitus Type 1hermeneutic phenomenological methodChronic DiseaseHealth Facility Environmentlived experienceFemaleFundamentals and skillsHospitalized childrenThematic analysisbusinessChild HospitalizedGerontologyInternational Journal of Qualitative Studies on Health and Well-being
researchProduct

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-cont…

2008

Background Results of previous studies suggest that renin-angiotensin system blockers might reduce the burden of diabetic retinopathy. We therefore designed the DIabetic REtinopathy Candesartan Trials (DIRECT) Programme to assess whether candesartan could reduce the incidence and progression of retinopathy in type 1 diabetes. Methods Two randomised, double-blind, parallel-design, placebo-controlled trials were done in 309 centres worldwide. Participants with normotensive, normoalbuminuric type 1 diabetes without retinopathy were recruited to the DIRECT-Prevent 1 trial and those with existing retinopathy were recruited to DIRECT-Protect 1, and were assigned to candesartan 16 mg once a day or…

Retinopathy type 1 diabetes candesartanSettore MED/13 - Endocrinologia
researchProduct

Combined therapy with insulin and rGH in thirteen Italian patients with type 1 diabetes (T1DM) and growth disorders.

2012

Background: Combined GH and insulin therapy are rarely prescribed in pediatric pts because the association of GHD and T1DM is rare and maybe for the difficulties in managing a double therapy with opposite effects on glucose metabolism. Objective and hypotheses: To investigate on the attitude of pediatric endo-diabetologists in treating these pts. Methods: Data were collected from over 50 centres belonging to the ISPED. The inclusion criterion was based on the double therapy for at least 6 months with insulin due to T1DM, and rGH, due to growth impairment. Results: Most centres stated that the use of combined therapy was considered uncomfortable and frequently avoided, whereas 10 centres rep…

Settore MED/38 - Pediatria Generale E Specialisticatype 1 diabetesT1DM GHInsulin; GH; type 1 diabetesInsulinGH
researchProduct

HUMAN WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS IN PANCREATIC ISLET TRANSPLANTATION

Wharton's jelly mesenchymal stem cells Type 1 diabetes beta cellsSettore BIO/16 - Anatomia Umana
researchProduct

Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: A retrospective analysis

2018

Abstract Background Idiopathic type 1 diabetes mellitus (IDM) is characterized by an onset with insulinopenia and ketoacidosis with negative β-cell autoimmunity markers and lack of association with HLA. The aim of the study is to compare the clinical and metabolic parameters, the macro and microvascular complications, the adipose tissue dysfunction and the insulin secretion and sensitivity indexes in patients with IDM and autoimmune type 1 diabetes mellitus (ADM) at clinical onset. Methods Thirty patients with IDM and 30 with ADM, matched for age and gender, were retrospectively analyzed. BMI, waist circumference, lipids, glycemia, HbA1c, insulin requirement, glutamic oxaloacetic and glutam…

medicine.medical_specialtyType 1 diabetemedicine.medical_treatmentEndocrinology Diabetes and MetabolismAdipose tissue030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyGastroenterologyCardiovascular risk factorSettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineInsulin resistanceInternal medicineDiabetes mellitusmedicineInternal Medicinec-Peptideslcsh:RC620-627Cardiovascular risk factorsType 1 diabetesC-Peptidebusiness.industryInsulinResearchInsulin secretionInsulin resistancemedicine.diseaseKetoacidosislcsh:Nutritional diseases. Deficiency diseasesType 1 diabetesSteatosisC-Peptides; Cardiovascular risk factors; Insulin resistance; Insulin secretion; Type 1 diabetes; Internal Medicine; Endocrinology Diabetes and Metabolismbusiness
researchProduct

Use of basal insulin analog detemir in pregnant women with type 1 diabetes: a case-control retrospective study

2012

pregnant type 1 diabetes
researchProduct